Montpellier, France

J Elle Taillades, Born Arnaud


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: J Elle Taillades: Innovator in Angiotensin II Antagonists

Introduction

J Elle Taillades, born Arnaud, is a notable inventor based in Montpellier, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as angiotensin II antagonists. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Taillades holds a patent for Imidazolines, which relates to compounds of a specific formula. These compounds, defined by the variables R1 to R5 in the specification, are recognized for their utility as angiotensin II antagonists. This invention represents a crucial step in the development of treatments for conditions related to the angiotensin II pathway.

Career Highlights

Throughout his career, J Elle Taillades has been associated with Sanofi, a leading global healthcare company. His role at Sanofi has allowed him to collaborate with other experts in the field, further enhancing his contributions to pharmaceutical innovations. His work has not only advanced scientific knowledge but has also had a tangible impact on patient care.

Collaborations

One of his notable collaborators is Bernard Ferrari, with whom he has worked closely on various projects. Their partnership exemplifies the importance of teamwork in the pursuit of groundbreaking medical advancements.

Conclusion

J Elle Taillades is a distinguished inventor whose work in the field of angiotensin II antagonists has made a significant impact on pharmaceutical science. His patent for Imidazolines highlights his innovative spirit and commitment to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…